GLOB­AL BIOEN­ER­GIES part­ners with AUDI on drop-in biofuel

Glob­al Bioen­er­gies, a NYSE Altern­ext Par­is lis­ted com­pany (ALGBE),is a pion­eer in the devel­op­ment o fpro­cesses for the dir­ect and cost-effi­cient trans­form­a­tion of renew­able resources into light olefins, the key build­ing blocks of the pet­ro­chem­ic­al industry. Its most advanced pro­gram con­sists in the pro­duc­tion of bio-isob­utene, a molecule with mul­tiple applic­a­tions, one of which allows its trans­form­a­tion into isooctane, the gold­stand­ard for gas­ol­ine engines (octane num­ber 100). As a 100% drop-in fuel, it can be used in any blend­ing ratio with all stand­ard fuels for gas­ol­ine motors. It does not present the draw­backs asso­ci­ated with alco­hol-based bio­fuels such as eth­an­ol or isobutan­ol which lead to lim­ited blend­ing ratios and lower mileage per liter.

Audi is a fron­trun­ner at imple­ment­ing sus­tain­able solu­tions for all aspects dir­ectly linked to its products. Three para­met­ers are key to Audi in push­ing for­ward the devel­op­ment of new bio­fuels: the qual­ity of the fuel to ensure optim­al com­pat­ib­il­ity with its engines, the envir­on­ment­al foot­print in par­tic­u­lar regard­ing CO2 emis­sions and the require­ment to use feed­stock not in com­pet­i­tion with eat­able resources.

Thomas Buhl, Head of Busi­ness Devel­op­ment­at Glob­al Bioen­er­gies com­ments: ​“We had recently announced the start of our pre-com­mer­cial pilot phase at the Fraunhofer CBP in Leuna allow­ing obtain­ing high-pur­ity isob­utene which can be used for dif­fer­ent applic­a­tions. One cru­cial point of our col­lab­or­a­tion with Audi will con­sist in sup­ply­ing them with isooctane derived from our isob­utene to be pro­duced at that pilot. Fur­ther­more, the col­lab­or­a­tion with Audi will enable us to emphas­ize even more the usage of sus­tain­able feed­stock.“

Dur­ing the two-year col­lab­or­a­tion, this agree­ment also fore­sees the pos­sib­il­ity for Audi to acquire shares of Glob­al Bioen­er­gies cor­res­pond­ing to less than 2% of its cap­it­al.

About GLOB­AL BIOENERGIES 

Glob­al Bioen­er­gies is one of the few com­pan­ies world­wide, and the only one in Europe, that is devel­op­ing a pro­cess to con­vert renew­able resources into hydro­car­bons through fer­ment­a­tion. The Com­pany ini­tially focused its efforts on the pro­duc­tion of isob­utene, one of the most import­ant pet­ro­chem­ic­al build­ing blocks that can be con­ver­ted into fuels, plastics, organ­ic glass and elast­omers. Glob­al Bioen­er­gies con­tin­ues to improve the yield of its pro­cess and is act­ively enter­ing the indus­tri­al pilot test­ing phase. The com­pany recently rep­lic­ated this suc­cess to pro­pyl­ene and butadiene and is also look­ing to con­tin­ue with oth­er mem­bers of the gaseous olefins fam­ily, key molecules at the heart of pet­ro­chem­ic­al industry. Glob­al Bioen­er­gies is lis­ted on NYSE Altern­ext Par­is (FR0011052257 — ALGBE).

Source: Glob­al Bioenergies